Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment

NCT03309202 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer